Naturopathic Drug Erythema Multiforme Major: A Rare Case Report

Full Article PDF Review History

Published: 2023-07-13

Page: 132-137

Saraswathi K. Gopal

Department of Oral Medicine and Radiology, Meenakshi Ammal Dental College and Hospitals, Meenakshi Institute of Higher Science and Research, Chennai, India.

N. Sindhuja *

Department of Oral Medicine and Radiology, Meenakshi Ammal Dental College and Hospitals, Meenakshi Institute of Higher Science and Research, Chennai, India.

*Author to whom correspondence should be addressed.


Erythema multiforme (EM) is an acute self-limiting hypersensitive mucocutaneous lesion with varied etiologies. It is classified as a spectrum of disorders with Erythema multiforme minor, Erythema multiforme major. Herpes virus infection is considered to be involved in more than 90% of cases. Drug-associated EM is rare and reported to be less than 10%. EM affects most commonly teenagers and young adults with more predilection to males. Oral lesions are seen on the lips and buccal mucosa which appear as erythematous macules, and bloody encrustations involving lips with classic target-like lesions. Here is a case report of erythema multiforme major which was induced by naturopathic medications in a middle-aged woman who presented with classic target lesions and was effectively treated with systemic corticosteroids which showed complete remission and no recurrence had been noted to date.

Keywords: Erythema multiforme, mucocutaneous lesions, target lesion, drug-induced, case report

How to Cite

Gopal , Saraswathi K., and N. Sindhuja. 2023. “Naturopathic Drug Erythema Multiforme Major: A Rare Case Report”. International Journal of Research and Reports in Dentistry 6 (2):132-37.


Download data is not yet available.


Nazir K Ali. Drug induced erythema multiforme-oral variant: A case report. Oral and Maxillofacial Surgery Cases. 2022; 81(1):00241,ISSN 2214-5419,

Monteiro GR, Máximo G, Coelho MCF, Da Silva Peralta F, Kitakawa D, De Carvalho LFCS. Erythema multiforme: A case report with oral manifestations. Int J Case Rep Images. 2022;13(2):61–65.

Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: A review for the practicing dermatologist. Int J Dermatol. 2012;51 (8):889-902.

Assier H, Bastuji-Garin S, Revuz J, et al. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol. 1995;131(5):539-543.

Trayes KP, Love G, Studdiford JS. Erythema multiforme: Recognition and management. Am Fam Physician. 2019; 100(2):82-88.

Asif Shaik Mohamed MDS, PhDa, Shamsudeen Shaik Mohamed MDSa, Assiri Khalil Ibrahim MDSa, Muburak Hussain Mohammed Al MDS, PhDa Kaleem, Sultan Mohammed MDSa; Khan Abdul Ahad MDSb, Shariff Mansoor MDSc. Drug induced oral erythema multiforme: Case Report. Medicine. 2021;100(17):p e22387, April 30,

Hebra F. Diseases of the skin. London, New Sydenham Society. 1866;I:1866–80.

Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophthalmia. Am J Dis Child. 1922;24:526–33.

Roujeau J-C. Erythema multiforme. In: Wolff K, Goldsmith LA, Katz SI, et al., eds. Fitzpatrick’s Dermatology in General Medicine, 7th ed. McGraw-Hill; 2008.

Schalock PC, Dinulos JG, Pace N, et al. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol. 2006;23(6):546-555.

Khalil I, Lepage V, Douay C, et al. HLA DQB1*0301 allele is involved in the susceptibility to Erythema multiforme. J Invest Dermatol 1991;97:697–700.

Weedon D. Weedon’s Skin Pathology, 3rd edn. Edinburgh: Churchill Livingstone/ Elsevier. 2010; 50–53, 202–207, 536–538.

Ono F, Sharma BK, Smith CC, et al. CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM). J Invest Dermatol. 2005;124:1215–1224.

Huff JC. Erythema multiforme. Dermatol Clin. 1985;3:141–152.

Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria and causes. J Am Acad Dermatol. 1983;8: 763–775.

Paulino L, Hamblin J, Osondu N, et al. (October 16, 2018) Variants of erythema multiforme: A Case Report and Literature Review. Cureus 10(10):3459.

DOI: 10.7759/cureus.3459

Kohli PS, Kaur J. Erythema multiforme-oral variant: Case report and review of literature. Indian J Otolaryngol Head Neck Surg. 2011;63(Suppl 1):9-12.

DOI: 10.1007/s12070-011-0169-y. Epub 2011 Apr 5. PMID: 22754823; PMCID: PMC3146678.

French LE, Prins C. Erythema multiforme, Stevens– Johnson syndrome and toxic epidermal necrolysis. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology, 2nd edn, Vol. 1. St Louis, MO: Mosby Elsevier. 2008:287–300.

Ayangco L, Rogers RS 3rd. Oral manifestations of erythema multiforme. Dermatol Clin. 2003; 21:195.

Stewart MG, Duncan III NO, Franklin DJ, et al. Head and neck manifestations of erythema multiforme in children. Otolaryngol Head Neck Surg. 1994; 111:236–24.